PILOTS

PILOT 1

Cardiovascular Affordability Accelerator. Why first: cardiovascular disease remains the leading cause of death globally, and this area offers practical, measurable affordability gains within 36 months.

PILOT 2

Diabetes Continuity and Insulin Access Pathway. Focus: lower treatment interruption through practical cost-reduction and access partnerships.

PILOT 3

Secondary Prevention Polypill Access Pilot. Focus: simplify long-term therapy after heart attack or stroke and reduce cost-related drop-off.

SIMPLE TIMELINE

  1. Months 1–6: Partner recruitment and target selection.
  2. Months 7–18: Pilot structuring and launch
  3. Months 19–30: Expansion and evidence generation.
  4. Months 31–36: Evaluation, replication planning, and biologics-readiness transition.

JOIN US IN BUILDING THE NEXT GENERATION OF AFFORDABLE MEDICINE ACCESS

 

Access4One is building and scaling a practical, partnership-driven platform that lowers the cost of bringing essential medicines to patients. We invite donors and partners to help create lasting, sustainable impact in the United States and around the world.